The Flexible, Robust, Equipment-free Microfluidic (FREM) platform for malaria screening and Plasmodium species genotyping.
One in five patients on Nirmatrelvir–Ritonavir experience virologic rebound, new observational study reveals
The frequency of viral rebound (VR) among acute coronavirus disease 2019 patients.